CURR RHEUMATOL REP 润色咨询

Current Rheumatology Reports

出版年份：暂无数据 年文章数：882 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：2.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2139683, encodeId=9ac3213968342, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Mon May 29 13:49:41 CST 2023, time=2023-05-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=580062, encodeId=5a475800625a, content=说得对<span class="quote">V587-Ivy 2019-11-06 发表::<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span><span class="quote">V587-Ivy 2019-11-06 00:00:00 发表:<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span>, beContent=V587-Ivy 2019-11-06 发表:: 亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Mon Nov 18 00:00:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579430, encodeId=71275e9430dd, content=亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Nov 06 00:00:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579353, encodeId=e2f35e93539e, content=仅接受约稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab5220796, createdName=15256541134_49193604, createdTime=Mon Nov 04 20:40:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578748, encodeId=26a05e8748e8, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577987, encodeId=dd0f5e798774, content=有没有投稿近两月，还处于接收状态的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846849, encodeId=b29a84684956, content=在风湿病这块的文章还是很好的，值得看一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Fri Aug 31 17:19:17 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2023-05-29 梁丽玲 来自浙江省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：6-12周

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2139683, encodeId=9ac3213968342, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Mon May 29 13:49:41 CST 2023, time=2023-05-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=580062, encodeId=5a475800625a, content=说得对<span class="quote">V587-Ivy 2019-11-06 发表::<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span><span class="quote">V587-Ivy 2019-11-06 00:00:00 发表:<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span>, beContent=V587-Ivy 2019-11-06 发表:: 亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Mon Nov 18 00:00:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579430, encodeId=71275e9430dd, content=亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Nov 06 00:00:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579353, encodeId=e2f35e93539e, content=仅接受约稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab5220796, createdName=15256541134_49193604, createdTime=Mon Nov 04 20:40:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578748, encodeId=26a05e8748e8, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577987, encodeId=dd0f5e798774, content=有没有投稿近两月，还处于接收状态的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846849, encodeId=b29a84684956, content=在风湿病这块的文章还是很好的，值得看一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Fri Aug 31 17:19:17 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2019-11-18 146ad228m80暂无昵称

    说得对V587-Ivy 2019-11-06 发表::
    亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！    V587-Ivy 2019-11-06 00:00:00 发表:
    亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！

    V587-Ivy 2019-11-06 发表:: 亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2139683, encodeId=9ac3213968342, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Mon May 29 13:49:41 CST 2023, time=2023-05-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=580062, encodeId=5a475800625a, content=说得对<span class="quote">V587-Ivy 2019-11-06 发表::<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span><span class="quote">V587-Ivy 2019-11-06 00:00:00 发表:<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span>, beContent=V587-Ivy 2019-11-06 发表:: 亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Mon Nov 18 00:00:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579430, encodeId=71275e9430dd, content=亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Nov 06 00:00:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579353, encodeId=e2f35e93539e, content=仅接受约稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab5220796, createdName=15256541134_49193604, createdTime=Mon Nov 04 20:40:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578748, encodeId=26a05e8748e8, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577987, encodeId=dd0f5e798774, content=有没有投稿近两月，还处于接收状态的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846849, encodeId=b29a84684956, content=在风湿病这块的文章还是很好的，值得看一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Fri Aug 31 17:19:17 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2019-11-06 V587-Ivy

    亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2139683, encodeId=9ac3213968342, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Mon May 29 13:49:41 CST 2023, time=2023-05-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=580062, encodeId=5a475800625a, content=说得对<span class="quote">V587-Ivy 2019-11-06 发表::<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span><span class="quote">V587-Ivy 2019-11-06 00:00:00 发表:<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span>, beContent=V587-Ivy 2019-11-06 发表:: 亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Mon Nov 18 00:00:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579430, encodeId=71275e9430dd, content=亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Nov 06 00:00:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579353, encodeId=e2f35e93539e, content=仅接受约稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab5220796, createdName=15256541134_49193604, createdTime=Mon Nov 04 20:40:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578748, encodeId=26a05e8748e8, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577987, encodeId=dd0f5e798774, content=有没有投稿近两月，还处于接收状态的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846849, encodeId=b29a84684956, content=在风湿病这块的文章还是很好的，值得看一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Fri Aug 31 17:19:17 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2019-11-04 15256541134_49193604

    仅接受约稿。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2139683, encodeId=9ac3213968342, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Mon May 29 13:49:41 CST 2023, time=2023-05-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=580062, encodeId=5a475800625a, content=说得对<span class="quote">V587-Ivy 2019-11-06 发表::<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span><span class="quote">V587-Ivy 2019-11-06 00:00:00 发表:<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span>, beContent=V587-Ivy 2019-11-06 发表:: 亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Mon Nov 18 00:00:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579430, encodeId=71275e9430dd, content=亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Nov 06 00:00:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579353, encodeId=e2f35e93539e, content=仅接受约稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab5220796, createdName=15256541134_49193604, createdTime=Mon Nov 04 20:40:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578748, encodeId=26a05e8748e8, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577987, encodeId=dd0f5e798774, content=有没有投稿近两月，还处于接收状态的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846849, encodeId=b29a84684956, content=在风湿病这块的文章还是很好的，值得看一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Fri Aug 31 17:19:17 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    求经验求分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2139683, encodeId=9ac3213968342, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Mon May 29 13:49:41 CST 2023, time=2023-05-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=580062, encodeId=5a475800625a, content=说得对<span class="quote">V587-Ivy 2019-11-06 发表::<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span><span class="quote">V587-Ivy 2019-11-06 00:00:00 发表:<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span>, beContent=V587-Ivy 2019-11-06 发表:: 亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Mon Nov 18 00:00:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579430, encodeId=71275e9430dd, content=亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Nov 06 00:00:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579353, encodeId=e2f35e93539e, content=仅接受约稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab5220796, createdName=15256541134_49193604, createdTime=Mon Nov 04 20:40:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578748, encodeId=26a05e8748e8, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577987, encodeId=dd0f5e798774, content=有没有投稿近两月，还处于接收状态的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846849, encodeId=b29a84684956, content=在风湿病这块的文章还是很好的，值得看一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Fri Aug 31 17:19:17 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2019-10-16 V587-Ivy

    有没有投稿近两月，还处于接收状态的么？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2139683, encodeId=9ac3213968342, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Mon May 29 13:49:41 CST 2023, time=2023-05-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=580062, encodeId=5a475800625a, content=说得对<span class="quote">V587-Ivy 2019-11-06 发表::<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span><span class="quote">V587-Ivy 2019-11-06 00:00:00 发表:<br>亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！</span>, beContent=V587-Ivy 2019-11-06 发表:: 亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7905157744, createdName=146ad228m80暂无昵称, createdTime=Mon Nov 18 00:00:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579430, encodeId=71275e9430dd, content=亲们，这个杂志仅接受约稿，其他的一概不看的，如果有投稿很长时间还处于“submitted”状态的，赶紧给编辑写邮件要求撤稿啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Nov 06 00:00:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579353, encodeId=e2f35e93539e, content=仅接受约稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab5220796, createdName=15256541134_49193604, createdTime=Mon Nov 04 20:40:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578748, encodeId=26a05e8748e8, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577987, encodeId=dd0f5e798774, content=有没有投稿近两月，还处于接收状态的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/f4e672c4d5e08009f21ced10357005e0.jpg, createdBy=950d5107525, createdName=V587-Ivy, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846849, encodeId=b29a84684956, content=在风湿病这块的文章还是很好的，值得看一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Fri Aug 31 17:19:17 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2018-08-31 ms4895215858607754

    在风湿病这块的文章还是很好的，值得看一下。

    0

共8条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分